Tech Company Financing Transactions
Precision Therapeutics Funding Round
Precision Therapeutics, based in Eagan, secured $20 million from Quaker Partners, Adams Capital Management and Birchmere Ventures.
Transaction Overview
Company Name
Announced On
2/21/2006
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Investors
Quaker Partners (Lead Investor) (Richard Kollender)
Proceeds Purpose
This funding will allow us to move forward quickly on new research programs that could further enhance ChemoFx as a tool broadly used in developing individualized chemotherapy regimens.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
2915 Commers Dr. 900
Eagan, MN 55121
USA
Eagan, MN 55121
USA
Phone
Email Address
Overview
Precision Therapeutics is an oncology services company dedicated to the individualization of cancer therapy. Precision Therapeutics is a leader in the development and delivery of treatment support tools that assist physicians and benefit cancer patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carl Schwartz
Chief Financial Officer
Robert Myers
Chief Operating Officer
David Johnson
VP - Product Management
David Dauwalter
Browse more venture capital transactions:
Prev: 2/21/2006: BakBone Software venture capital transaction
Next: 2/22/2006: Aesthera venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs